Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions (3D)

This study has been completed.
Information provided by:
Cordis Corporation Identifier:
First received: October 4, 2005
Last updated: November 17, 2009
Last verified: November 2009